CN103483462A - Preparation method for phascolosoma esculenta polysaccharide and application of phascolosoma esculenta polysaccharide in treating septicemia - Google Patents
Preparation method for phascolosoma esculenta polysaccharide and application of phascolosoma esculenta polysaccharide in treating septicemia Download PDFInfo
- Publication number
- CN103483462A CN103483462A CN201310433313.1A CN201310433313A CN103483462A CN 103483462 A CN103483462 A CN 103483462A CN 201310433313 A CN201310433313 A CN 201310433313A CN 103483462 A CN103483462 A CN 103483462A
- Authority
- CN
- China
- Prior art keywords
- phascolosoma
- polysaccharide
- enzyme
- solution
- enzymolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a preparation method for a phascolosoma esculenta polysaccharide and application of the phascolosoma esculenta polysaccharide. Endogenous enzyme killing is firstly performed on phascolosoma esculenta power, then enzymolysis is performed on the phascolosoma esculenta power through a combined enzyme formed by subtilisin and Alacase protease, and after tri-filtering on the enzymatic hydrolysate, the phascolosoma esculenta polysaccharide is obtained through vacuum concentration and drying. The preparation method has the advantages that the preparation is simple, the deproteinization process and the ethyl alcohol precipitation process are eliminated, the production period is shortened, energy conservation, emission reduction and environment protection are facilitated, the enzymolysis effect is still good, and the content of polysaccharide in the phascolosoma esculenta polysaccharide can reach 50 to 70 percent. The phascolosoma esculenta polysaccharide has the effect of resisting septicemia.
Description
Technical field
The present invention relates to the making method of siphon-worm polysaccharide, be specifically related to the application at antisepsis of a kind of preparation method of Phascolosoma polysaccharide and Phascolosoma polysaccharide.
Background technology
Phascolosoma (
phascolosoma esculenta), be under the jurisdiction of the sipunculan door, be China's native species, be distributed widely in the coastland on the south entrance of Changjiang River, output is abundant.Phascolosoma is the marine organisms of high protein and low fat.Having put down in writing its edible and pharmaceutical use in the multiple book on Chinese herbal medicine of China, is China's folk tradition medicine food excellent tonic product, and some area replaces Chinese medicine Cordyceps sinensis with it.The various active materials such as Phascolosoma rich in proteins and polysaccharide, can regulate the multiple function of body.For a long time, Phascolosoma is mainly used in eating, but the application for a patent for invention of publication number CN102153666A, the preparation method of ocean siphon-worm polysaccharide and the application in anti-fatigue effect are disclosed, its preparation method is the pancreatin solution added in the siphon-worm raw material under alkaline solution or alkalescence, then heating is extracted and is obtained Crude polysaccharides, also disclose in this application for a patent for invention with trichoroacetic acid(TCA) and sloughed siphon-worm albumen and ethanol alcohol precipitation process (generally need spend the night or standing 12h), after deproteinated, the siphon-worm polysaccharide content can reach more than 80%.This application for a patent for invention discloses the effect that the siphon-worm polysaccharide has antifatigue, specifically can increase mouse swimming time etc.
Summary of the invention
The purpose of this invention is to provide a kind of Phascolosoma polyoses producing method, the method has been save deproteinated technique and ethanol alcohol precipitation process, makes simply, and in the Phascolosoma polysaccharide obtained, polysaccharide content still reaches 50~70%.The invention also discloses the effect that the Phascolosoma polysaccharide has antisepsis.
Technical problem to be solved by this invention is a kind of preparation method of Phascolosoma polysaccharide, and step is as follows:
A, by impurity elimination, after going the Phascolosoma of internal organ to clean, pulverize, the endogenous enzyme 10min that goes out at 100 ℃ of temperature, obtain the Phascolosoma powder;
B, add distilled water and combination enzyme in the Phascolosoma powder, stir as Phascolosoma solution, Phascolosoma solution is enzymolysis 1.5~2.5h under 45~55 ℃ of temperature condition, enzyme 15min goes out after enzymolysis under 85 ℃, go out and filter and obtain enzymolysis solution with 80~100 orders after enzyme, wherein in Phascolosoma solution, the weight ratio of Phascolosoma powder and distilled water is 1:5~10, in Phascolosoma solution, the weight percent final concentration of combination enzyme is 0.1~0.5%, the combination enzyme is formulated by subtilisin and the Alacase proteolytic enzyme of weight ratio 1:1,
C, by aperture 0.45mm filtering with microporous membrane for above-mentioned enzymolysis solution, the ultra-filtration membrane ultrafiltration that filtrate is 5000 ~ 10000 Da with molecular weight cut-off again obtains ultrafiltrated, ultrafiltrated vacuum concentration drying obtains the Phascolosoma polysaccharide.
The application of Phascolosoma polysaccharide in preparing the antisepsis medicine.Every day, oral dosage can be 100~500mg/day kg BW etc.
Compared with prior art the invention has the advantages that a kind of preparation method of Phascolosoma polysaccharide and the application of Phascolosoma polysaccharide, the Phascolosoma powder endogenous enzyme of first going out, the combination enzyme enzymolysis formed by subtilisin and Alacase proteolytic enzyme again, after the enzymolysis solution three-stage filtration, the vacuum concentration drying obtains the Phascolosoma polysaccharide, this preparation method makes simply, deproteinated technique and ethanol alcohol precipitation process have been save, shorten the production cycle, be conducive to reduce discharging energy-conservation and protection of the environment, hydrolysis result is still better, in the Phascolosoma polysaccharide obtained, polysaccharide content still reaches 50~70%.This Phascolosoma polysaccharide has the effect of antisepsis.
Embodiment
Below in conjunction with embodiment, the present invention is described in further detail.
Embodiment 1
Phascolosoma is removed to the impurity such as silt, internal organ, grinds after cleaning, the endogenous enzyme 10min that goes out at 100 ℃ of temperature, obtain 10 kilograms, Phascolosoma powder after cooling; Add 75 kilograms of distilled water and 0.2 kilogram of combination enzyme (subtilisin of weight ratio 1:1 and the preparation of Alacase proteolytic enzyme) in the Phascolosoma powder, stir as Phascolosoma solution, Phascolosoma solution is enzymolysis 1.5h under 45~55 ℃ of temperature condition, the enzyme 15min that goes out under 85 ℃ after enzymolysis, filter and obtain enzymolysis solution with 80~100 orders after the enzyme that goes out; By aperture 0.45mm filtering with microporous membrane for enzymolysis solution, the ultra-filtration membrane ultrafiltration that filtrate is 5000 ~ 10000 Da with molecular weight cut-off again obtains ultrafiltrated, ultrafiltrated vacuum concentration drying obtains the Phascolosoma polysaccharide, and measuring polysaccharide content in the Phascolosoma polysaccharide is 62%.
Embodiment 2
Substantially the same manner as Example 1, difference be distilled water be 50 kilograms, the combination enzyme be 0.07 kilogram, enzymolysis time is 2.5h, in the Phascolosoma polysaccharide, polysaccharide content is 50%.
Embodiment 3
Substantially the same manner as Example 1, difference be distilled water be 100 kilograms, the combination enzyme be 0.54 kilogram, enzymolysis time is 2.0h, in the Phascolosoma polysaccharide, polysaccharide content is 70%.
Application examples
300 mouse are divided into to siphon-worm polysaccharide group and control group at random, every group each 150, the continuous gavage of Phascolosoma polysaccharide of siphon-worm polysaccharide group use above-described embodiment 1 30 days, (200mg/day kg BW), 200 mg/day kg BW continuous normal saline gavage 30 days for control group, gavage finishes the vetanarcol anesthesia with 80 mg/kg by mouse, cut abdominal cavity and take out caecum, use the cotton thread ligation under ileocaecal sphineter, twice of No. 22 pinprick of caecum employing of ligation part, prepare ripe mouse septicemia model, caecum is put back to abdominal cavity, sew up abdominal cavity, obtain the septicemia mouse model.1, the septicemia mouse model to setting up, get each 50 of siphon-worm polysaccharide group and control groups, observes survival condition the record of a mouse every day, continues 8 days; After 8 days, control group septicemia mouse model is entirely dead, and 18 survivals of siphon-worm polysaccharide group septicemia mouse model illustrate that the siphon-worm polysaccharide can improve the survival rate of suffering from the septicemia mouse, and survival rate reaches 42%.2, to the septicemia mouse model of setting up, get each 50 of siphon-worm polysaccharide group and control groups, observe 3 days mouse of survival afterwards, get the mouse whole blood and win Mouse Liver and the spleen tissue, respectively to liver, after each tissue homogenate of spleen and blood, spread plate, 37 ° of C cultivate 18 h, calculate the colony number of each sample, the mouse colony number of siphon-worm polysaccharide group septicemia mouse model as a result: 17500 ± 531/milligram tissues of hepatic tissue colony number average out to, spleen is organized 51000 ± 648/milligram tissues of colony number average out to, 171000 ± 862/milligram tissues of haemal tissue colony number average out to, the mouse colony number of control group septicemia mouse model: 43200 ± 963/milligram tissues of hepatic tissue colony number average out to, spleen is organized 84600 ± 1854/milligram tissues of colony number average out to, 697000 ± 3731/milligram tissues of haemal tissue colony number average out to, illustrate that the Phascolosoma polysaccharide can reduce the pathogenic bacterium number of septicemia mouse.3, the septicemia mouse model to setting up, get each 50 of siphon-worm polysaccharide group and control groups, get the mouse whole blood lived after observing 24 h, add antithrombotics in blood, centrifugal 15 min of 3500 rpm, get blood plasma, adopt Enzyme Linked Immunoadsorbent Assay to detect proinflammatory inflammation factor interleukin-11 β and tumor necrosis factor alpha, the expression of anti-inflammatory factor IL-10, as a result in the mice plasma of siphon-worm polysaccharide group septicemia mouse model: interleukin-11 β average out to 665 ± 31pg/ml, tumor necrosis factor alpha average out to 574 ± 47pg/ml, IL-10 average out to 951 ± 62pg/ml; In the mice plasma of control group septicemia mouse model: interleukin-11 β average out to 1131 ± 91pg/ml, tumor necrosis factor alpha average out to 1263 ± 89pg/ml, IL-10 average out to 1013 ± 93pg/ml; Illustrate that the Phascolosoma polysaccharide can obviously reduce proinflammatory inflammation factor interleukin-11 β and the expression of tumor necrosis factor alpha in blood plasma in the septicemia mouse, and do not affect the expression of anti-inflammatory factor IL-10.
Toxicology detects
The Phascolosoma polysaccharide that adopts 1000 mg/day kg BW and two kinds of dosage of 10000 mg/day kg BW is continuously to mouse stomach 30 days, the mouse of 1000 mg/day kg BW dosage gavages does not demonstrate obvious toxicity sign as a result, and death does not occur the mouse of 10000 mg/day kg BW dosage gavages.
Claims (2)
1. the preparation method of a Phascolosoma polysaccharide is characterized in that step is as follows:
A, by impurity elimination, after going the Phascolosoma of internal organ to clean, pulverize, the endogenous enzyme 10min that goes out at 100 ℃ of temperature, obtain the Phascolosoma powder;
B, add distilled water and combination enzyme in the Phascolosoma powder, stir as Phascolosoma solution, Phascolosoma solution is enzymolysis 1.5~2.5h under 45~55 ℃ of temperature condition, enzyme 15min goes out after enzymolysis under 85 ℃, go out and filter and obtain enzymolysis solution with 80~100 orders after enzyme, wherein in Phascolosoma solution, the weight ratio of Phascolosoma powder and distilled water is 1:5~10, in Phascolosoma solution, the weight percent final concentration of combination enzyme is 0.1~0.5%, the combination enzyme is formulated by subtilisin and the Alacase proteolytic enzyme of weight ratio 1:1,
C, by aperture 0.45mm filtering with microporous membrane for above-mentioned enzymolysis solution, the ultra-filtration membrane ultrafiltration that filtrate is 5000 ~ 10000 Da with molecular weight cut-off again obtains ultrafiltrated, ultrafiltrated vacuum concentration drying obtains the Phascolosoma polysaccharide.
2. the application of Phascolosoma polysaccharide in preparing the antisepsis medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310433313.1A CN103483462B (en) | 2013-09-23 | 2013-09-23 | A kind of preparation method of Phascolosoma polysaccharide and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310433313.1A CN103483462B (en) | 2013-09-23 | 2013-09-23 | A kind of preparation method of Phascolosoma polysaccharide and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103483462A true CN103483462A (en) | 2014-01-01 |
CN103483462B CN103483462B (en) | 2015-12-23 |
Family
ID=49824094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310433313.1A Active CN103483462B (en) | 2013-09-23 | 2013-09-23 | A kind of preparation method of Phascolosoma polysaccharide and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103483462B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107163155A (en) * | 2017-05-09 | 2017-09-15 | 华侨大学 | A kind of preparation method and applications of Phascolosoma polysaccharide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586312A (en) * | 2004-08-27 | 2005-03-02 | 宁波大学 | Method for producing oyster biological active substance and its product |
CN1748714A (en) * | 2004-09-14 | 2006-03-22 | 李妍妍 | Method for preparing biological active substance of siphon-worm and its products |
-
2013
- 2013-09-23 CN CN201310433313.1A patent/CN103483462B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586312A (en) * | 2004-08-27 | 2005-03-02 | 宁波大学 | Method for producing oyster biological active substance and its product |
CN1748714A (en) * | 2004-09-14 | 2006-03-22 | 李妍妍 | Method for preparing biological active substance of siphon-worm and its products |
Non-Patent Citations (5)
Title |
---|
YONG-JIANG LOU ET AL.: "Protective role of the polysaccharides from sea cucumber,acaudina molpadioidea,in cecal ligation and puncture-induced sepsis", 《CURRENT TOPIC IN NUTRACEUTICAL RESEARCH》, vol. 11, no. 2, 31 May 2013 (2013-05-31), pages 29 - 34 * |
何江川 等: "超滤膜分离法在多糖分离提取中的应用", 《食用菌》, 31 December 2005 (2005-12-31), pages 5 - 7 * |
李妍妍 等: "可口革囊星虫体腔液多糖的研究", 《2007年全国生化与生物技术药物学术年会论文汇编》, 1 August 2008 (2008-08-01), pages 522 - 523 * |
李燕妮: "超滤法分离纯化刺参酸性粘多糖工艺研究", 《化学与生物工程》, vol. 26, no. 1, 31 December 2009 (2009-12-31) * |
李路军 等: "超滤膜分离纯化山麦冬多糖的研究", 《湖北大学学报(自然科学版)》, vol. 28, no. 3, 30 September 2006 (2006-09-30), pages 299 - 301 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107163155A (en) * | 2017-05-09 | 2017-09-15 | 华侨大学 | A kind of preparation method and applications of Phascolosoma polysaccharide |
CN107163155B (en) * | 2017-05-09 | 2020-03-24 | 华侨大学 | Preparation method and application of phascolosoma esculenta polysaccharide |
Also Published As
Publication number | Publication date |
---|---|
CN103483462B (en) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5517215B2 (en) | Fermentation and culture method, plant fermented extract, plant fermented extract powder and blended plant fermented extract | |
CN102994305B (en) | Method for preparing health-care food (therapy) product (nutrient juice wine) by use of extracts from cordyceps militaris and cocoon | |
CN102551064A (en) | Nutrient of fresh sea cucumbers and abalone and preparation method for nutrient | |
KR101705548B1 (en) | Composition for enhancing immune response comprising extract of Apios americana Medikus or fermented extract of the same | |
CN105410346A (en) | Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof | |
CN101919875B (en) | Preparation method of enteromorpha mushroom polysaccharide compound | |
CN112999261A (en) | Natto fermented composition capable of relieving arteriosclerosis and preparation method and application thereof | |
CN104757560A (en) | Glutathione yeast enzymolysis solution composition and preparation method thereof | |
CN106047974A (en) | Hippocampus polypeptide with antioxidant and anti-fatigue activity and preparation technology thereof | |
CN102318658B (en) | Frost-resisting fresh-water fish minced fillet and preparation method thereof | |
CN106011209A (en) | Preparation method of collagen peptide | |
CN103483462B (en) | A kind of preparation method of Phascolosoma polysaccharide and application | |
CN109593140B (en) | Gracilaria crispatus polysaccharide and preparation method and application thereof | |
KR100844980B1 (en) | Method of producing a Healthy Mulberry Leaf Food by culture of Mushroom Mycelia | |
CN116425897A (en) | Rosa roxburghii polysaccharide, and preparation method and application thereof | |
CN103695322B (en) | Be rich in phellinus igniarius mycelium product and the production method thereof of bioactive ingredients | |
KR101491493B1 (en) | Anti-inflammatory pharmaceutical composition comprising tangerine pericarp and Psidium guajava extract | |
CN102987408B (en) | Method for extracting nutritional ingredients such as free amino acids from waste cordyceps militaris cocoons | |
CN104256503A (en) | Snail soy sauce and manufacturing method thereof | |
CN112961259B (en) | Preparation method of taurolimus polysaccharide and application of taurolimus polysaccharide in field of improving intestinal function | |
KR102181220B1 (en) | Pharmaceutical composition for anti-cancer containing medicinal gerb extracts | |
KR20220090373A (en) | Health supplement food composition for improving respiratory diseases and health supplement food using the same | |
CN106260359A (en) | A kind of Saussurea involucrata culture compositions Ganoderma tea and preparation method thereof | |
KR20220020147A (en) | Method for preparing Phellinus linteus mycelia extract or Phellinus linteus mycelia extract powder and composition for enhancing immunity comprising them as an active ingredient | |
CN106884026B (en) | Active polysaccharide rich in flavonoid compounds and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |